First class and business class are where every traveler wants to be. Today, the lines between the two are starting to blur, ...

Contract Research Organization for the Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) Informed the Company ...

If you have kids in school, or even if you don’t, you’ve probably realized that there’s a lot about the day-to-day of school ...

Reached broad alignment with the FDA on the registration path for CRB-701 for 2L treatment in head and neck squamous cell carcinoma (HNSCC) and ...

Kyntra Bio, Inc. (NASDAQ: KYNB) Q1 2026 Earnings Call Transcript May 11, 2026 Kyntra Bio, Inc. misses on earnings expectations. Reported EPS is $-3.76 EPS, expectations were $-3.36.

Ford replaced the Explorer Timberline with the all-new 2026 Tremor—and added a 400-hp twin-turbo V6 as an option. I spent a ...

The accelerated pace of product launches, integrations, and partner activity positions eGain for further competitive ...

Q1 2026 Earnings Call May 14, 2026 4:30 PM EDTCompany ParticipantsRalph Clark - President, CEO & DirectorAlan Stewart - ...

Discusses Business Performance, Semiconductor Innovation and Energy Management Architecture May 13, 2026 12:30 PM ...

Dividend Distribution -- Monthly dividend of $0.17 per share through the end of Q2; more than six consecutive years of uninterrupted distributions highlighted. Total Return and ROE -- Year-to-date ...

Operator: Good afternoon, and welcome to Relmada Therapeutics First Quarter Earnings Conference Call. At this time, all ...

Payers have historically treated spine surgery as a default hospital procedure, but that assumption is increasingly at odds with clinical reality. Advances in minimally invasive techniques, enhanced ...